urine telomerase reverse transcriptase promotor gene mutation (uTERTpm)
Jump to navigation
Jump to search
Indications
- detection of bladder cancer[1]
* detectable years before the clinical diagnosis of bladder cancer[1]
Principle
Clinical significance
- TERT promoter mutations have been detected in 60-85% in all stages & grades of bladder cancers[1]
More general terms
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Nelson R Simple Urine Test Could Improve Detection of Bladder Cancer. Medscape. May 24, 2022 https://www.medscape.com/viewarticle/974499
International Agency for Research on Cancer (WHO) Improving Early Detection and Clinical Management of Bladder Cancer. A promising urine test (uTERTpm). https://www.iarc.who.int/wp-content/uploads/2022/05/IARC_Evidence_Summary_Brief_3.pdf